Producción de IFN−γ en cultivos de linfocitos humanos por efecto de los extractos metanólicos de cuatro ecotipos de Lepidium peruvianum, Chacón (Brassicaceae)

by Libertad Alzamora, Patricia Galván, Evelyn Alvarez, Dina Torres, Erasmo Colona, Madeley Aliaga, Álvaro Marcelo
Published 2013-05-01

Evaluation of postoperative pain and the use of complementary therapies by nursing

by Jorge Luis Rodríguez-Díaz, Gina Patricia Galván-López, Mariela Ximena Pacheco-Lombeida, Melynn Parcon-Bitanga
Published 2019-01-01

Polymorphisms in the calcium-sensing receptor gene are associated with clinical outcome of neuroblastoma.

by Laia Masvidal, Raquel Iniesta, Carla Casalà, Patricia Galván, Eva Rodríguez, Cinzia Lavarino, Jaume Mora, Carmen de Torres
Published 2013-01-01

The Hippo Transducer TAZ Interacts with the SWI/SNF Complex to Regulate Breast Epithelial Lineage Commitment

by Adam Skibinski, Jerrica L. Breindel, Aleix Prat, Patricia Galván, Elizabeth Smith, Andreas Rolfs, Piyush B. Gupta, Joshua LaBaer, Charlotte Kuperwasser
Published 2014-03-01

DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis.

by Gemma Mayol, José I Martín-Subero, José Ríos, Ana Queiros, Marta Kulis, Mariona Suñol, Manel Esteller, Soledad Gómez, Idoia Garcia, Carmen de Torres, Eva Rodríguez, Patricia Galván, Jaume Mora, Cinzia Lavarino
Published 2012-01-01

Connection between genetic polymorphism of interleukin -1 beta with chronic periodontitis in peruvian adults

by Ivonne F. Reyes-Mandujano, José E. Olivera-García, Manuel Taboada-Vega, Patricia Galvan-Sanchez, Amilcar Azcarza-Acuña, Aldo M. Yactayo-Flores, Luis A. Zuñiga-Ccoicca, Evelyn V. Leiva-Pachas, Efraín Paccori-García
Published 2018-04-01

Corrigendum: PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single...

by Sonia Pernas, Anna Petit, Fina Climent, Laia Paré, J. Perez-Martin, Luz Ventura, Milana Bergamino, Patricia Galván, Catalina Falo, Idoia Morilla, Adela Fernandez-Ortega, Agostina Stradella, Montse Rey, Amparo Garcia-Tejedor, Miguel Gil-Gil, Aleix Prat
Published 2019-09-01

PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution

by Sonia Pernas, Anna Petit, Fina Climent, Laia Paré, J. Perez-Martin, Luz Ventura, Milana Bergamino, Patricia Galván, Catalina Falo, Idoia Morilla, Adela Fernandez-Ortega, Agostina Stradella, Montse Rey, Amparo Garcia-Tejedor, Miguel Gil-Gil, Aleix Prat
Published 2019-08-01

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

by Olga Martínez-Sáez, Nuria Chic, Tomás Pascual, Barbara Adamo, Maria Vidal, Blanca González-Farré, Esther Sanfeliu, Francesco Schettini, Benedetta Conte, Fara Brasó-Maristany, Adela Rodríguez, Débora Martínez, Patricia Galván, Ana Belén Rodríguez, Antonio Martinez, Montserrat Muñoz, Aleix Prat
Published 2020-05-01

Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial

by Barbara Adamo, Meritxell Bellet, Laia Paré, Tomás Pascual, Maria Vidal, José A. Pérez Fidalgo, Salvador Blanch, Noelia Martinez, Laura Murillo, Patricia Gómez-Pardo, Ana López-González, Kepa Amillano, Jordi Canes, Patricia Galván, Blanca González-Farré, Xavier González, Patricia Villagrasa, Eva Ciruelos, Aleix Prat
Published 2019-09-01

Multispecies Evaluation of a Long-Acting Tenofovir Alafenamide Subdermal Implant for HIV Prophylaxis

by Manjula Gunawardana, Mariana Remedios-Chan, Debbie Sanchez, Simon Webster, Patricia Galvan, Rob Fanter, Amalia E. Castonguay, Paul Webster, John A. Moss, Joseph Kuo, Philippe A. Gallay, Kathleen L. Vincent, Massoud Motamedi, Dana Weinberger, Mark A. Marzinke, Mark A. Marzinke, Craig W. Hendrix, Marc M. Baum
Published 2020-11-01

Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population

by Jorge Gómez-Miragaya, Marta Palafox, Laia Paré, Guillermo Yoldi, Irene Ferrer, Sergi Vila, Patricia Galván, Pasquale Pellegrini, Hector Pérez-Montoyo, Ana Igea, Purificación Muñoz, Manel Esteller, Angel R. Nebreda, Ander Urruticoechea, Idoia Morilla, Sonia Pernas, Fina Climent, María Teresa Soler-Monso, Ana Petit, Violeta Serra, Aleix Prat, Eva González-Suárez
Published 2017-05-01

Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy

by Nuria Chic, Francesco Schettini, Fara Brasó-Maristany, Esther Sanfeliu, Barbara Adamo, Maria Vidal, Débora Martínez, Patricia Galván, Blanca González-Farré, Javier Cortés, Joaquín Gavilá, Cristina Saura, Mafalda Oliveira, Sònia Pernas, Olga Martínez-Sáez, Jesús Soberino, Eva Ciruelos, Lisa A. Carey, Montserrat Muñoz, Charles M. Perou, Tomás Pascual, Meritxell Bellet, Aleix Prat
Published 2021-07-01

Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy

by Olga Martínez-Sáez, Tomás Pascual, Fara Brasó-Maristany, Nuria Chic, Blanca González-Farré, Esther Sanfeliu, Adela Rodríguez, Débora Martínez, Patricia Galván, Anna Belén Rodríguez, Francesco Schettini, Benedetta Conte, Maria Vidal, Barbara Adamo, Antoni Martínez, Montserrat Muñoz, Reinaldo Moreno, Patricia Villagrasa, Fernando Salvador, Eva M. Ciruelos, Iris Faull, Justin I. Odegaard, Aleix Prat
Published 2021-02-01

Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade

by Fara Brasó-Maristany, Gaia Griguolo, Tomás Pascual, Laia Paré, Paolo Nuciforo, Antonio Llombart-Cussac, Begoña Bermejo, Mafalda Oliveira, Serafín Morales, Noelia Martínez, Maria Vidal, Barbara Adamo, Olga Martínez, Sonia Pernas, Rafael López, Montserrat Muñoz, Núria Chic, Patricia Galván, Isabel Garau, Luis Manso, Jesús Alarcón, Eduardo Martínez, Sara Gregorio, Roger R. Gomis, Patricia Villagrasa, Javier Cortés, Eva Ciruelos, Aleix Prat
Published 2020-01-01

RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer

by Adrián Sanz-Moreno, Sonia Palomeras, Kim Pedersen, Beatriz Morancho, Tomas Pascual, Patricia Galván, Sandra Benítez, Jorge Gomez-Miragaya, Marina Ciscar, Maria Jimenez, Sonia Pernas, Anna Petit, María Teresa Soler-Monsó, Gemma Viñas, Mansour Alsaleem, Emad A. Rakha, Andrew R. Green, Patricia G. Santamaria, Celine Mulder, Simone Lemeer, Joaquin Arribas, Aleix Prat, Teresa Puig, Eva Gonzalez-Suarez
Published 2021-03-01

<i>ERBB2</i> mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer

by Gaia Griguolo, Fara Brasó-Maristany, Blanca González-Farré, Tomás Pascual, Núria Chic, Tamara Saurí, Ronald Kates, Oleg Gluz, Débora Martínez, Laia Paré, Vassilena Tsvetkova, David Pesantez, Maria Vidal, Barbara Adamo, Montserrat Muñoz, Patricia Galván, Laura Barberá, Miriam Cuatrecasas, Mathias Christgen, Hans Kreipe, Inés Monge-Escartín, Patricia Villagrasa, Dolors Soy, Tommaso Giarratano, Maria Vittoria Dieci, Pierfranco Conte, Nadia Harbeck, Valentina Guarneri, Aleix Prat
Published 2020-07-01

A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer

by Tomás Pascual, Tomás Pascual, Miguel Martin, Miguel Martin, Miguel Martin, Aranzazu Fernández-Martínez, Laia Paré, Laia Paré, Emilio Alba, Emilio Alba, Emilio Alba, Álvaro Rodríguez-Lescure, Álvaro Rodríguez-Lescure, Giuseppe Perrone, Javier Cortés, Javier Cortés, Serafín Morales, Ana Lluch, Ana Lluch, Ana Lluch, Ana Lluch, Ana Lluch, Ander Urruticoechea, Blanca González-Farré, Blanca González-Farré, Patricia Galván, Pedro Jares, Adela Rodriguez, Nuria Chic, Daniela Righi, Juan Miguel Cejalvo, Giuseppe Tonini, Barbara Adamo, Maria Vidal, Patricia Villagrasa, Montserrat Muñoz, Aleix Prat, Aleix Prat
Published 2019-04-01